Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats
Carcinogenesis develops in stages that have been operationally defined as initiation, promotion and progression. Although morphological end points have been described for detection and quantitation of these stages, to date initiation has been assessed only in the context of clonal growth in response...
Saved in:
Published in | Carcinogenesis (New York) Vol. 15; no. 11; p. 2587 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.11.1994
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Carcinogenesis develops in stages that have been operationally defined as initiation, promotion and progression. Although morphological end points have been described for detection and quantitation of these stages, to date initiation has been assessed only in the context of clonal growth in response to certain promoting agents. Initiated cells are morphologically indistinguishable from surrounding cells and early changes at the cellular level during initiation have not been clarified. One commonly used end point for the detection of preneoplastic hepatic lesions i their aberrant expression of the placental isozyme of glutathione S-transferase (PGST). Because single hepatocytes expressing PGST have been detected in aged rats and in those administered hepatocarcinogens, it has been suggested that such cells constitute a population of putatively initiated hepatocytes. In order to further elucidate the characteristics of single PGST-positive hepatocytes, we analyzed the number of these cells 2 and 18 weeks after various doses (0-100 mg/kg) of diethylnitrosamine (DEN) and of dimethylbenz[a]anthracene (DMBA). When determined 14 days after carcinogen administration, the number of single hepatocytes expressing PGST was greater after DEN administration (ranging from 0.8 +/- 0.3 per cm2 transection of liver at 1 mg/kg to 33.0 +/- 4.7 at 100 mg/kg) than after DMBA administration (ranging from 0.25 +/- 0.14 at 10 mg/kg to 3.03 +/- 0.5 at 100 mg/kg); none were detected in control rats of the same age. Additional rats were maintained on a basal diet or a basal diet plus phenobarbital for a further 4 month period. Whereas individual PGST-positive hepatocytes were only sporadically detected in rats treated with DMBA and maintained on a basal diet for 18 weeks, those rats placed on phenobarbital for 16 weeks had an even higher number of such PGST-positive hepatocytes than at 2 weeks after DMBA administration. In contrast, the dose-response curve observed for DEN-treated rats 18 weeks after carcinogen administration was similar to that observed 2 weeks after carcinogen treatment for both phenobarbital- and non-phenobarbital-treated rats. In addition, the number of single PGST-positive hepatocytes detected at 2 weeks was directly parallel to the number of altered hepatic foci expressing PGST 18 weeks after DEN administration. The dose-dependent induction of PGST-positive single hepatocytes after treatment with two hepatocarcinogens, the dose-dependent growth of altered hepatic foci (AHF) expressing PGST with phenobarbital administration and the parallel dose-response curve of single hepatocytes expressing PGST and later of AHF expressing PGST argue strongly for a precursor role of single PGST-positive cells in the development of AHF expressing PGST. |
---|---|
AbstractList | Carcinogenesis develops in stages that have been operationally defined as initiation, promotion and progression. Although morphological end points have been described for detection and quantitation of these stages, to date initiation has been assessed only in the context of clonal growth in response to certain promoting agents. Initiated cells are morphologically indistinguishable from surrounding cells and early changes at the cellular level during initiation have not been clarified. One commonly used end point for the detection of preneoplastic hepatic lesions i their aberrant expression of the placental isozyme of glutathione S-transferase (PGST). Because single hepatocytes expressing PGST have been detected in aged rats and in those administered hepatocarcinogens, it has been suggested that such cells constitute a population of putatively initiated hepatocytes. In order to further elucidate the characteristics of single PGST-positive hepatocytes, we analyzed the number of these cells 2 and 18 weeks after various doses (0-100 mg/kg) of diethylnitrosamine (DEN) and of dimethylbenz[a]anthracene (DMBA). When determined 14 days after carcinogen administration, the number of single hepatocytes expressing PGST was greater after DEN administration (ranging from 0.8 +/- 0.3 per cm2 transection of liver at 1 mg/kg to 33.0 +/- 4.7 at 100 mg/kg) than after DMBA administration (ranging from 0.25 +/- 0.14 at 10 mg/kg to 3.03 +/- 0.5 at 100 mg/kg); none were detected in control rats of the same age. Additional rats were maintained on a basal diet or a basal diet plus phenobarbital for a further 4 month period. Whereas individual PGST-positive hepatocytes were only sporadically detected in rats treated with DMBA and maintained on a basal diet for 18 weeks, those rats placed on phenobarbital for 16 weeks had an even higher number of such PGST-positive hepatocytes than at 2 weeks after DMBA administration. In contrast, the dose-response curve observed for DEN-treated rats 18 weeks after carcinogen administration was similar to that observed 2 weeks after carcinogen treatment for both phenobarbital- and non-phenobarbital-treated rats. In addition, the number of single PGST-positive hepatocytes detected at 2 weeks was directly parallel to the number of altered hepatic foci expressing PGST 18 weeks after DEN administration. The dose-dependent induction of PGST-positive single hepatocytes after treatment with two hepatocarcinogens, the dose-dependent growth of altered hepatic foci (AHF) expressing PGST with phenobarbital administration and the parallel dose-response curve of single hepatocytes expressing PGST and later of AHF expressing PGST argue strongly for a precursor role of single PGST-positive cells in the development of AHF expressing PGST. |
Author | Vaughan, J Pitot, H C Baker, K Mass, M Dragan, Y P Campbell, H A |
Author_xml | – sequence: 1 givenname: Y P surname: Dragan fullname: Dragan, Y P organization: McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706 – sequence: 2 givenname: H A surname: Campbell fullname: Campbell, H A – sequence: 3 givenname: K surname: Baker fullname: Baker, K – sequence: 4 givenname: J surname: Vaughan fullname: Vaughan, J – sequence: 5 givenname: M surname: Mass fullname: Mass, M – sequence: 6 givenname: H C surname: Pitot fullname: Pitot, H C |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7955110$$D View this record in MEDLINE/PubMed |
BookMark | eNotj89KAzEYxHOo1Lb6AB6EvEDa_Nnsbo5SrAoFD-q5fEm-7a5ss0uSgr69i-1pmPnBMLMkszAEJORB8LXgRm0cRNeFjdBrIdZS19WMLLgoFFNKFbdkmdI356JU2szJvDJaC8EXpN0NDnoKwdOpjzX_rsURcuco_owRU-qGQIeGjj04DHnix_6cIbdTjvSD5QghNRghIe0CvewYjhgmgpDR0wg53ZGbBvqE91ddka_d8-f2le3fX962T3vmFDeZidobW9uyKAu0lbMcBErupYJKKl6bxljhK6W1sZJbrIVyXJcIUnvkZa3kijxeesezPaE_jLE7Qfw9XB_LPx09Wow |
CitedBy_id | crossref_primary_10_1016_S0304_3835_97_04602_8 crossref_primary_10_1111_j_1349_7006_2007_00626_x crossref_primary_10_1177_019262339602400116 crossref_primary_10_1007_BF01261401 crossref_primary_10_1016_j_cbi_2006_03_007 crossref_primary_10_1111_liv_12773 crossref_primary_10_1016_j_biopha_2007_02_009 crossref_primary_10_1016_S0304_3835_99_00051_8 crossref_primary_10_1207_S15327914NC382_11 crossref_primary_10_1590_S0004_28032006000200012 crossref_primary_10_1016_j_ejca_2009_04_014 crossref_primary_10_1016_S0304_3835_01_00594_8 crossref_primary_10_3109_10715760903338071 crossref_primary_10_1016_j_ejca_2007_05_005 crossref_primary_10_1016_S0378_8741_02_00171_X crossref_primary_10_1093_toxsci_kfr314 crossref_primary_10_1177_109158189801700308 crossref_primary_10_1016_0304_3835_95_03789_Y crossref_primary_10_1016_S0304_3835_96_04568_5 crossref_primary_10_1586_17512433_1_6_759 crossref_primary_10_1080_15287394_2014_887423 crossref_primary_10_1371_journal_pone_0025707 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1093/carcin/15.11.2587 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 7955110 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: CA-45700 – fundername: NCI NIH HHS grantid: CA-22484 – fundername: NCI NIH HHS grantid: CA-07175 |
GroupedDBID | --- -E4 .2P .55 .GJ .I3 .ZR 0R~ 18M 1TH 29B 2WC 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6.Y 6J9 70D A8Z AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT ABEFU ABEUO ABIXL ABJNI ABKDP ABLJU ABMNT ABNHQ ABNKS ABPTD ABQLI ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACMRT ACNCT ACPQN ACPRK ACUFI ACUTJ ACUTO ACZBC ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFGWE AFIYH AFOFC AFRAH AFSHK AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AHMBA AHXPO AIAGR AIJHB AJEEA AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVNTJ AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM BZKNY C1A C45 CAG CDBKE CGR COF CS3 CUY CVF CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBD EBS ECM EE~ EIF EIHJH EJD ELUNK EMOBN ESTFP F5P F9B FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK FRP GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 KAQDR KBUDW KOP KQ8 KSI KSN M-Z M49 MBLQV MBTAY N9A NGC NLBLG NOMLY NOYVH NPM NTWIH NU- NVLIB O0~ O9- OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RHF RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TCN TEORI TJX TLC TMA TR2 W8F WOQ X7H X7M XOL YAYTL YKOAZ YXANX ZGI ZKB ZKX ZXP ~91 |
ID | FETCH-LOGICAL-c309t-18d9b8b6464eb7cb0a1e20d23a723089f9b1d73559b20be813c056ea25de06832 |
ISSN | 0143-3334 |
IngestDate | Wed Oct 16 00:48:19 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c309t-18d9b8b6464eb7cb0a1e20d23a723089f9b1d73559b20be813c056ea25de06832 |
PMID | 7955110 |
ParticipantIDs | pubmed_primary_7955110 |
PublicationCentury | 1900 |
PublicationDate | 1994-11-00 |
PublicationDateYYYYMMDD | 1994-11-01 |
PublicationDate_xml | – month: 11 year: 1994 text: 1994-11-00 |
PublicationDecade | 1990 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Carcinogenesis (New York) |
PublicationTitleAlternate | Carcinogenesis |
PublicationYear | 1994 |
SSID | ssj0016359 |
Score | 1.6654197 |
Snippet | Carcinogenesis develops in stages that have been operationally defined as initiation, promotion and progression. Although morphological end points have been... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 2587 |
SubjectTerms | 9,10-Dimethyl-1,2-benzanthracene Animals Diethylnitrosamine Dose-Response Relationship, Drug Female Glutathione Transferase - analysis Isoenzymes - analysis Liver - enzymology Liver Neoplasms, Experimental - enzymology Placenta - enzymology Precancerous Conditions - enzymology Rats Rats, Sprague-Dawley |
Title | Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7955110 |
Volume | 15 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELUKCMQFsVXs8oGr2yTOekSFqqoEFygqJ2Q7TsuBtipBQtz5b8ZLFsoi4BK1dpo4mVf7-XlmjNCpK0KHikAQJ2SS-AGLCXciTtLQk8AmWCaYkgYur8LewO8Pg2Gj8VbzWnrOeUu8fhlX8h-rQhnYVUXJ_sGy5UWhAD6DfeEIFobjr2zcnRah_jCJJ5n-NpYznYRVvlgXV80HteuVDnwcQYOUx-EU2OU1yTVvlXMYy5TyIdTOQpMp3JBoD3Rgo4CQpzqD7ZSnSJXL5MNmPqWocD5nI6Os3lUBZPVljl5dQy0cO4qSW_Y8Gpuf9ytVQqcXdktVohAqKaHUCpVFTxvUEeXW-83ADLufOnST7Mo8vRIZAujjW4tng1Vmj9rGUQIM0PjJ_li5kGPb1iyhpShW3eSVknzsUhQwssT4wZoHKpbGE9o2zWpXjVpHq_ZSC7MUzVZuNtGGnWbgM4OZLdSQk220dmkdKXbQWEMHA3RwCR1soYMr6OBphkvo4Bp08Afo4IcJ_gwdrKCziwbdi5tOj9hNN4igTpITN04THvPQD33JI8Ed5krPST3KIpitxkmWcDeNgKUm3HO4jF0qgENL5gWpdEIYH5poGRou9xD2VDa3lKWM09hnMQNmGMB01uVSBadG2T5qmnd0PzOZVe7tyzv4ruIQrVdgO0IrGfyR5TGwwpyfaKu9A7yXYMA |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Focal+and+non-focal+hepatic+expression+of+placental+glutathione+S-transferase+in+carcinogen-treated+rats&rft.jtitle=Carcinogenesis+%28New+York%29&rft.au=Dragan%2C+Y+P&rft.au=Campbell%2C+H+A&rft.au=Baker%2C+K&rft.au=Vaughan%2C+J&rft.date=1994-11-01&rft.issn=0143-3334&rft.volume=15&rft.issue=11&rft.spage=2587&rft_id=info:doi/10.1093%2Fcarcin%2F15.11.2587&rft_id=info%3Apmid%2F7955110&rft_id=info%3Apmid%2F7955110&rft.externalDocID=7955110 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3334&client=summon |